Get started
Author

Mesude Bicak

ORCID: 0000-0002-4546-9801
Observed ORCID: 0000-0002-4546-9801
OpenAlex ID: A5137545562
miR155, triplicated in Down syndrome, regulates the development of neural stem cells and GABAergic interneurons in Alzheimer's disease mouse and human iPSC models
2026 · Xiaodong Zhu, Jean‐Vianney Haure‐Mirande, et al. · Alzheimer s & Dementia
POSTER: AML-347: MYELOVAC: A Phase 1 Trial of a Personalized Peptide-Based Neoantigen Vaccination Platform in Combination With Hypomethylating Agent–Based Therapy for Patients With Acute Myeloid Leukemia in First Complete Remission Ineligible for Intensive Chemotherapy and Allogeneic Stem Cell Transplantation
2026 · Nikolaos Spyrou, Cansu Cimen Bozkus, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-347: MYELOVAC: A Phase 1 Trial of a Personalized Peptide-Based Neoantigen Vaccination Platform in Combination With Hypomethylating Agent–Based Therapy for Patients With Acute Myeloid Leukemia in First Complete Remission Ineligible for Intensive Chemotherapy and Allogeneic Stem Cell Transplantation
2026 · Nikolaos Spyrou, Cansu Cimen Bozkus, et al. · Clinical Lymphoma Myeloma & Leukemia
Figure S6 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Tables S1-S4 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S13 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S11 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S9 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S3 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S5 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S15 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S12 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S14 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S2 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S16 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S18 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S1 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S4 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S10 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S17 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Data from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S8 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Figure S7 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Table S5 from A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
2026 · Michelle A. Tran, Byuri Angela Cho, et al.
Works count: 24
Citation count:
H-index:
I10-index:
Year
Topic
Type